AVROBIO, Inc. AVRO
Set alert
1.40 0.00 0.00%
At close · Jun 20
1.38 Day range 1.44
52-week range unavailable
- Open
- 1.43
- Prev close
- 1.40
- Mkt cap
- 5.24M
- Vol
- 204.38K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.38
- High
- 1.44
- Forward P/E
- -8.24
- Beta
- 1.22
- Short ratio
- 0.70
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 16.17
- 200-d avg
- 16.46
- 1y target
- 2.00
Analyst view
Consensus: hold
Hold
Price target (mean) 2.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 1
- 2 months ago 2
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08 | -0.08 – -0.08 | 1.52 | -105.3% | 0 | 0.0% | 1 |
| Next quarter | -0.10 | -0.10 – -0.10 | -0.44 | +77.3% | 0 | 0.0% | 1 |
| Current year | -0.48 | -0.48 – -0.48 | 0.31 | -254.8% | 0 | 0.0% | 1 |
| Next year | -0.17 | -0.17 – -0.17 | -0.48 | +64.6% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 12, 2023 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 11, 2023 | Wedbush | Downgrade | Outperform | Neutral |
| Mar 23, 2023 | Mizuho | Maintained | — | Buy |
| Mar 23, 2023 | Needham | Reiterated | — | Buy |
| Dec 7, 2022 | BTIG | Upgrade | Neutral | Buy |
| May 16, 2022 | Needham | Maintained | — | Buy |
| May 10, 2022 | Barclays | Maintained | — | Overweight |
| Jan 5, 2022 | Mizuho | Maintained | — | Buy |
| Jan 4, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 4, 2022 | Needham | Maintained | — | Buy |
| Jan 4, 2022 | BTIG | Downgrade | Buy | Neutral |
| Jan 4, 2022 | Barclays | Maintained | — | Overweight |
| Nov 18, 2021 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Oct 11, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Jul 15, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Jun 14, 2021 | BTIG | Initiated | — | Buy |
| May 26, 2021 | Needham | Maintained | — | Buy |
| May 13, 2021 | Morgan Stanley | Maintained | — | Overweight |
| May 2, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Mar 8, 2021 | Barclays | Initiated | — | Overweight |
| Mar 1, 2021 | Stifel | Initiated | — | Hold |
| Nov 10, 2020 | Berenberg | Initiated | — | Buy |
| Oct 12, 2020 | Morgan Stanley | Maintained | — | Overweight |
| Jul 14, 2020 | Morgan Stanley | Maintained | — | Overweight |
| Mar 30, 2020 | Morgan Stanley | Maintained | — | Overweight |
| Mar 30, 2020 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Mar 30, 2020 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Feb 11, 2020 | Morgan Stanley | Maintained | — | Overweight |
| Nov 10, 2019 | Wedbush | Maintained | — | Outperform |
| Oct 27, 2019 | Nomura | Initiated | — | Buy |